Continuous Positive Airway Pressure for the Treatment of Supine Hypertension and Orthostatic Hypotension in Autonomic Failure. Issue 3 (5th January 2023)

• Record Type: Journal Article
• Authors: Okamoto, Luis E.; Celedonio, Jorge E.; Smith, Emily C.; Paranjape, Sachin Y.; Black, Bonnie K.; Wahba, Amr; Park, Jin-Woo; Shibao, Cyndya A.; Diedrich, André; Biaggioni, Italo
• Is Part Of: Hypertension. Volume 80:Issue 3(2022)
• Page Start: 650
• Page End: 658
• Publication Date: 2023-01-05
• Subjects: autonomic failure -- continuous positive airway pressure -- nocturia -- orthostatic hypotension -- supine hypertension; Hypertension -- Periodicals; Hypertension -- Treatment -- Periodicals; 616.132005
• DOI: 10.1161/HYPERTENSIONAHA.122.20081
• Languages: English
• ISSNs: 0194-911X

Abstract

Abstract : Background: Supine hypertension affects most patients with orthostatic hypotension (OH) due to autonomic failure, but it is often untreated for fear of worsening OH. We hypothesized that increasing intrathoracic pressure with continuous positive airway pressure (CPAP) had a Valsalva-like blood-pressure-lowering effect that could be used to treat nocturnal supine hypertension in these patients, while reducing nocturnal pressure diuresis and improving daytime OH. Methods: In Protocol 1, we determined the acute hemodynamic effects of increasing levels of CPAP (0, 4, 8, 12, and 16 cm H2 O, 3 minutes each) in 26 patients with autonomic failure and supine hypertension studied while awake and supine. In Protocol 2 (n=11), we compared the effects of overnight therapy with CPAP (8–12 cm H2 O for 8 hours) versus placebo on nocturnal supine hypertension, nocturnal diuresis and daytime OH in a 2-night crossover study. Results: In Protocol 1, acute CPAP (4–16 cm H2 O) decreased systolic blood pressure in a dose-dependent manner (maximal drop 22±4 mmHg with CPAP 16) due to reductions in stroke volume (−16+3%) and cardiac output (−14±3%). Systemic vascular resistance and heart rate remained unchanged. In Protocol 2, overnight CPAP lowered nighttime systolic blood pressure (maximal change −23±5 versus placebo −1±7 mmHg; P =0.023) and was associated with lower nighttime diuresis (609±84 versus placebo 1004±160 mL; P =0.004) and improved morning orthostatic tolerance (AUC upright SBP 642±121 versus placebo 410±109 mmHg*min; P =0.014). Conclusions: CPAP is a novel nonpharmacologic approach to treat the supine hypertension of autonomic failure while improving nocturia and daytime OH. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03312556.